ERBB2 and neoplasm: The therapeutic effect of anti-Amot vaccination was mediated by the induction of specific antibodies that induced increased tumor vessel permeability, which, in turn, resulted in both an increase in chemotherapy efficacy and major epitope spreading, which was accompanied by the induction of a specific anti-HER2 antibody response that further contrasted tumor growth [93].